# Magnesium Sulfate and Trigger Points

> **NCT06975813** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Fayoum University** · enrollment: 30 (estimated)

## Conditions studied

- Myofascial Pain Syndrome

## Interventions

- **DRUG:** masseter muscle
- **DRUG:** masseter and sternocleidomastoid muscle

## Key facts

- **NCT ID:** NCT06975813
- **Lead sponsor:** Fayoum University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2025-12-30
- **Final completion:** 2026-01-27
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06975813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06975813, "Magnesium Sulfate and Trigger Points". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT06975813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*